From: Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance
Diameter of the inhibitory zone (mm) Mean ± SEM (n = 5) | |||||||
---|---|---|---|---|---|---|---|
Antibiotic | Control | Antibiotic + SR 10 μ g ml −1 | Antibiotic + SR 20 μg ml −1 | Antibiotic + SR 40 μg ml −1 | Antibiotic + SR 60 μg ml −1 | Antibiotic + SR 80 μg ml −1 | Antibiotic + SR 100 μg ml −1 |
Ciprofloxacin 5 μg | 21.50 ± 0.70 | 22.25 ± 0.50 | 24 ± 1.41 | 29 ± 1.40 | 30 ± 4.24* | 37 ± 2.82** | 39.5 ± 2.12** |
Levofloxacin 5 μg | 20.50 ± 0.70 | 21.70 ± 0.00 | 23 ± 1.41 | 25.50 ± 0.70 | 26.50 ± 0.70 | 33 ± 5.65* | 36.5 ± 4.94** |
Norfloxacin 10 μg | 16.50 ± 0.70 | 17.5 ± 0.50 | 20.50 ± 2.12 | 21 ± 1.41 | 24 ± 1.41 | 34.5 ± 7.77* | 36.5 ± 7.77* |
Moxifloxacin 5 μg | 22 ± 1.41 | 22 ± 0.00 | 23 ± 1.41 | 26.50 ± 0.70 | 28.50 ± 0.70 | 34.50 ± 4.94* | 37.5 ± 3.53** |
Cefexime 5 μg | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 |
Cloxacillin 5 μg | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 |
Gentamicin10 μg | 21.50 ± 0.70 | 22.50 ± 0.20 | 24.5 ± 0.70 | 27.50 ± 0.70** | 29 ± 1.41** | 35 ± 1.41*** | 36.5 ± 0.7*** |